Trevi Therapeutics, Inc. · NASDAQ:TRVI
FMR LLC reported a 8.80% stake in Trevi Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 6, 2026
FMR LLC reported a 8.80% stake in Trevi Therapeutics, Inc., 12,562,839 shares, as a passive investor on Jun 30, 2026. Filed Aug 6, 2026 (Schedule 13G/A).
- Stake
- 8.80%
- Shares
- 12,562,839
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 8.80% | 12,562,839 |
| Abigail P. Johnson | 8.80% | 12,562,839 |
Source
Related
- Trevi Therapeutics, Inc.
- FMR LLC
- Trevi Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G · FMR LLC · Feb 5, 2026
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · May 7, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Feb 13, 2026
- Schedule 13G/A · Rubric Capital Management LP · Feb 13, 2026